Skip to main content

Table 1 Clinical characteristics of 182 ICC patients (unmatched) based on cNFIB expression levels

From: CircNFIB inhibits tumor growth and metastasis through suppressing MEK1/ERK signaling in intrahepatic cholangiocarcinoma

Variables

Low cNFIB

(n = 91)

High cNFIB

(n = 91)

P value

Age, year, > 60/≤60

46/45

37/54

0.1804

Gender, male/female

Ascites, present/absent

54/37

8/83

46/45

11/80

0.2333

0.4671

Hepatolithiasis, present/absent

3/88

2/89

0.6502

HbsAg, positive/negative

28/63

23/68

0.4092

CA19–9, > 22/≤22

65/26

56/35

0.1576

Tumor size (cm), > 5/≤5

54/37

47/44

0.2965

Tumor number, multiple/solitary

38/53

20/71

0.0042

Differentiation, poor/well-moderate

73/18

58/33

0.0133

MVI, present/absent

12/79

8/83

0.3431

Lymph node, positive/negative

22/69

11/80

0.0343

Cirrhosis, with/without

7/84

11/80

0.3206

TNM stage, III/I- II

70/21

49/42

0.0011

  1. ICC intrahepatic cholangiocarcinoma; MVI microvascular invasion; TNM tumor-node-metastasis